184 related articles for article (PubMed ID: 1394811)
1. Prophylactic chemotherapy for primary and recurrent superficial bladder cancer: preliminary results. The Hokkaido University Bladder Cancer Collaborating Group.
Togashi M; Shinohara N; Toyota K; Koyanagi T; Maru A; Fujieda J; Kawakura K; Nishida T; Ohashi N
Cancer Chemother Pharmacol; 1992; 30 Suppl():S21-5. PubMed ID: 1394811
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy with early intravesical instillation of adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer. The Kyushu University Urological Oncology Group.
Ueda T; Naito S; Iguchi A; Sagiyama K; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
Cancer Chemother Pharmacol; 1992; 30 Suppl():S31-6. PubMed ID: 1394813
[TBL] [Abstract][Full Text] [Related]
3. [Postoperative intravesical installation of tetrahydropyranyl-adriamycin (THP) and cytosine arabinoside (CA) for superficial bladder cancer: clinical results of prophylactic effects on recurrence].
Hashimoto H; Yachiku S; Watabe Y; Niibori D; Yamauchi K; Osanai H; Ohashi K; Wakabayashi A; Fujisawa M
Gan To Kagaku Ryoho; 1994 May; 21(6):833-8. PubMed ID: 8185341
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer--intravesical thio-TEPA versus oral UFT.
Hirao Y; Okajima E; Ozono S; Samma S; Sasaki K; Hiramatsu T; Babaya K; Watanabe S; Maruyama Y
Cancer Chemother Pharmacol; 1992; 30 Suppl():S26-30. PubMed ID: 1394812
[TBL] [Abstract][Full Text] [Related]
5. Significance of the preoperative intravesical instillation of doxorubicin and the oral administration of 5-fluorouracil in preventing recurrence after a transurethral resection of superficial bladder cancer. Kyushu University Urological Oncology Group.
Naito S; Iguchi A; Sagiyama K; Ariyoshi A; Osada Y; Omoto T; Kuriya N; Kumazawa J
Int J Urol; 1997 Jul; 4(4):352-7. PubMed ID: 9256323
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer.
Tsushima T; Matsumura Y; Ozaki Y; Yoshimoto J; Ohmori H
Cancer Chemother Pharmacol; 1987; 20 Suppl():S72-6. PubMed ID: 3117400
[TBL] [Abstract][Full Text] [Related]
7. [Intravesical instillation chemotherapy of anticancer agents including cylocide: studies of prophylactic effects on the recurrence].
Yasumoto R; Asakawa M; Yoshihara H; Sakamoto W; Iseki T; Nakatani T; Wada S; Kishimoto T; Maekawa M; Nishio S
Hinyokika Kiyo; 1990 Apr; 36(4):407-13. PubMed ID: 2116082
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of intravesical instillation therapy of superficial bladder tumor--combination therapy of mitomycin C, adriamycin, peplomycin and cytosine arabinoside].
Kinoshita N; Tochigi H; Yanagawa M; Yamakawa K; Sakurai M; Hioki T; Kawamura J
Hinyokika Kiyo; 1990 Mar; 36(3):257-63. PubMed ID: 1693807
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone. The Kyushu University Urological Oncology Group.
Naito S; Kotoh S; Omoto T; Osada Y; Sagiyama K; Iguchi A; Ariyoshi A; Hiratsuka Y; Kumazawa J
Cancer Chemother Pharmacol; 1998; 42(5):367-72. PubMed ID: 9771950
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic chemotherapy with anthracyclines (adriamycin, epirubicin, and pirarubicin) for primary superficial bladder cancer. The Hokkaido University Bladder Cancer Collaborative Group.
Shinohara N; Nonomura K; Tanaka M; Nagamori S; Takakura F; Seki T; Koyanagi T; Togashi M; Maru A
Cancer Chemother Pharmacol; 1994; 35 Suppl():S41-5. PubMed ID: 7994785
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic intravesical chemotherapy with adriamycin plus verapamil for primary superficial bladder cancer: preliminary results. The Kyushu University Urological Oncology Group.
Naito S; Ueda T; Kotoh S; Iguchi A; Sagiyama K; Hiratsuka Y; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
Cancer Chemother Pharmacol; 1994; 35 Suppl():S76-80. PubMed ID: 7994792
[TBL] [Abstract][Full Text] [Related]
12. Early intravesical instillation of adriamycin with oral administration of 5-fluorouracil after transurethral resection for superficial bladder cancer: preliminary results.
Ueda T; Iguchi A; Sagiyama K; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
Cancer Chemother Pharmacol; 1987; 20 Suppl():S81-4. PubMed ID: 3664948
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic chemotherapy with intravesical instillation of adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer. The Japanese Urological Cancer Research Group for Adriamycin.
Obata K; Ohashi Y; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Matsumura Y; Niijima T
Cancer Chemother Pharmacol; 1994; 35 Suppl():S88-92. PubMed ID: 7994795
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of intravesical chemoprophylaxis of superficial bladder cancer: experience of the Japanese Urological Cancer Research Group for Adriamycin.
Akaza H; Koiso K; Kotake T; Matsumura Y; Isaka S; Machida T; Obata K; Ohashi Y; Ohe H; Ohi Y
Cancer Chemother Pharmacol; 1992; 30 Suppl():S15-20. PubMed ID: 1394810
[TBL] [Abstract][Full Text] [Related]
15. [Prophylactic intravesical instillation therapy in patients with superficial bladder cancer--results of a randomized prospective study].
Tsushima T; Nasu Y; Abeki N; Noda M; Saika T; Ohmori H; Kobashi K; Ozaki Y; Matsumura Y; Tanahashi T
Nihon Hinyokika Gakkai Zasshi; 1992 Aug; 83(8):1314-21. PubMed ID: 1405170
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group.
Akaza H; Isaka S; Koiso K; Kotake T; Machida T; Maru A; Matsumura Y; Niijima T; Obata K; Ohe H
Cancer Chemother Pharmacol; 1987; 20 Suppl():S91-6. PubMed ID: 3117403
[TBL] [Abstract][Full Text] [Related]
17. Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder cancer.
Isaka S; Okano T; Abe K; Shimazaki J
Cancer Chemother Pharmacol; 1992; 30 Suppl():S41-4. PubMed ID: 1394815
[TBL] [Abstract][Full Text] [Related]
18. [Instillation chemotherapy with peplomycin in superficial bladder cancer: clinical study on the effects of the direct antitumor activity and of the prophylaxis of recurrence].
Sonoda T; Osafune M; Matsuda M; Usami M
Hinyokika Kiyo; 1988 Mar; 34(3):574-81. PubMed ID: 2455442
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of prophylactic intravesical chemotherapy with epirubicin in the treatment of superficial bladder cancer. Tokyo Women's Medical College Bladder Cancer Collaborating Group.
Ryoji O; Toma H; Nakazawa H; Goya N; Okumura T; Sonoda T; Kihara T; Tanabe K; Onizuka S; Tomoe H
Cancer Chemother Pharmacol; 1994; 35 Suppl():S60-4. PubMed ID: 7994789
[TBL] [Abstract][Full Text] [Related]
20. Cytostatic intravesical instillation in patients with superficial bladder carcinoma for the prevention of recurrent tumors.
Huland H; Klöppel G; Otto U; Feddersen I; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F
Eur Urol; 1988; 14(3):202-6. PubMed ID: 3133216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
